UNIVERSITY OF FLORIDA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1853-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ufl.edu
The Effect of Exercise on Neurorecovery Following Mild Traumatic Brain Injury
Not Applicable
Completed
- Conditions
- Brain Concussion
- Interventions
- Behavioral: Aerobic ExerciseBehavioral: Non-Aerobic Exercise
- First Posted Date
- 2014-10-27
- Last Posted Date
- 2018-12-04
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 39
- Registration Number
- NCT02276079
- Locations
- 🇺🇸
University of Florida Health Science Center, Gainesville, Florida, United States
Persistent Post-Surgical Pain in Women With BrCA
Completed
- Conditions
- Breast CancerChronic Pain
- First Posted Date
- 2014-10-16
- Last Posted Date
- 2018-12-28
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 5
- Registration Number
- NCT02266082
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
Oval-8 Splinting Versus Standardized Treatment With Tee Pee or Forearm Based Thumb Spica Splinting
Not Applicable
Withdrawn
- Conditions
- Carpometacarpal (CMC) Joint Arthritis
- Interventions
- Device: Oval-8 SplintDevice: Tee Pee SplintDevice: Forearm Based Splint
- First Posted Date
- 2014-10-16
- Last Posted Date
- 2016-11-04
- Lead Sponsor
- University of Florida
- Registration Number
- NCT02266095
- Locations
- 🇺🇸
UF Health Orthopaedics - Jacksonville (Emerson), Jacksonville, Florida, United States
Phase I, Dose Escalation Study of Decitabine
Phase 1
Completed
- Conditions
- Leukemia, Lymphoblastic, AcuteHematopoetic MyelodysplasiaLeukemia, Myeloid Acute
- Interventions
- First Posted Date
- 2014-10-15
- Last Posted Date
- 2018-10-15
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 3
- Registration Number
- NCT02264873
- Locations
- 🇺🇸
UF Health Shands Hospital, Gainesville, Florida, United States
Developmental Outcomes
Completed
- Conditions
- Hypoxic-Ischemic Encephalopathy
- Interventions
- Other: Developmental Outcomes
- First Posted Date
- 2014-10-15
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 21
- Registration Number
- NCT02264808
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
Florida Neonatal Neurologic Network
- Conditions
- Hypoxic-Ischemic Encephalopathy
- Interventions
- Other: Database Entry/Biospecimen Collection
- First Posted Date
- 2014-10-09
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 1000
- Registration Number
- NCT02260271
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
Airway Muscle Training for Obstructive Sleep Apnea
Not Applicable
Completed
- Conditions
- Obstructive Sleep Apnea
- Interventions
- Device: Respiratory muscle strength trainingDevice: Sham respiratory muscle strength training
- First Posted Date
- 2014-10-08
- Last Posted Date
- 2018-04-11
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 47
- Registration Number
- NCT02259660
- Locations
- 🇺🇸
UFHealth Sleep Center, Gainesville, Florida, United States
Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome
Phase 4
Completed
- Conditions
- Stable AnginaMetabolic Syndrome
- Interventions
- Other: PlaceboDrug: Ranolazine
- First Posted Date
- 2014-09-30
- Last Posted Date
- 2020-04-10
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 33
- Registration Number
- NCT02252406
- Locations
- 🇺🇸
University of Florida, Jacksonville, Florida, United States
Pain, Brain and Mobility Study
Withdrawn
- Conditions
- Clinical PainBrain and Mobility Changes
- Interventions
- Procedure: Quantitative Sensory Testing (QST)Procedure: Physical PerformanceProcedure: Magnetic Resonance Imaging (MRI)Procedure: Blood Sample
- First Posted Date
- 2014-09-15
- Last Posted Date
- 2016-02-18
- Lead Sponsor
- University of Florida
- Registration Number
- NCT02240303
Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease
Phase 1
Completed
- Conditions
- Pompe Disease
- Interventions
- Genetic: Recombinant Adeno-Associated Virus Acid Alpha-GlucosidaseOther: salineDrug: RapamycinDrug: RituxanDrug: DiphenhydramineDrug: AcetaminophenDrug: LidocaineDrug: LMX 4 Topical Cream
- First Posted Date
- 2014-09-15
- Last Posted Date
- 2022-04-05
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 2
- Registration Number
- NCT02240407
- Locations
- 🇺🇸
Clinical and Translational Research Building (CTRB), University of Florida, Gainesville, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath